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One of the hallmarks of cancer growth and metastatic spread is the process of local invasion
of the surrounding tissue. Cancer cells achieve protease-dependent invasion by the secre-
tion of enzymes involved in proteolysis. These overly expressed proteolytic enzymes then
proceed to degrade the host tissue allowing the cancer cells to disseminate throughout
the microenvironment by active migration and interaction with components of the extra-
cellular matrix (ECM) such as collagen. In this paper we develop a mathematical model of
cancer invasion which consider the role of matrix metalloproteinases (MMPs). Specifically
our model will focus on two distinct types of MMP, i.e., soluble, diffusible MMPs (e.g.,
MMP-2) and membrane-bound MMPs (e.g., MT1-MMP), and the roles each of these plays
in cancer invasion.The implications of MMP-2 activation by MMP-14 and the tissue inhibitor
of metalloproteinases-2 are considered alongside the effect the architecture of the matrix
may have when applied to a model of cancer invasion. Elements of the ECM architecture
investigated include pore size of the matrix, since in some highly dense collagen structures
such as breast tissue, the cancer cells are unable to physically fit through a porous region,
and the crosslinking of collagen fibers. In this scenario, cancer cells rely on membrane-
bound MMPs to forge a path through which degradation by other MMPs and movement
of cancer cells becomes possible.
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INTRODUCTION
For metastasis to occur, cancer cells must exhibit invasion through
a variety of structured media such as the highly dense collagen
constitution of some peritumoral stroma (Hanahan and Wein-
berg, 2000, 2011). This can occur by the secretion of enzymes that
are capable of degrading components of the ECM or by the adop-
tion of an amoeboid phenotype that allows cancer cells to travel
through the medium in a protease-independent manner (Friedl
and Wolf, 2003; Sahai, 2005).
Mathematical modeling of solid-tumor growth dates back to
the works of Thomlinson and Gray (1955) and Burton (1966),
where oxygen was modeled as a nutrient diffusing from the outer
edge (boundary) of a tumor inwards to investigate its role in necro-
sis. Mathematical modeling has continued to develop to investigate
a number of topics in cancer progression and invasion, includ-
ing models taking into account: oxygen/nutrient driven dynamics,
the immune response, the acidity of the environment, force-
based pressure, the microenvironment in general, and protease-
dependent invasion using the techniques of partial differential
equations for densities of cells, individual-based models includ-
ing cellular automaton models and multi-scale models as outlined
in the review papers of Araujo and McElwain (2004), Rejniak and
McCawley (2010), and Lowengrub et al. (2010) and the references
therein.
In this paper, we focus on a continuum, deterministic approach
to protease-dependent invasion where matrix degrading enzymes
cleave collagen fibrils and other ECM components rather than
protease-independent invasion where mechanical forces physically
displace matrix fibrils and cancer cells adopt an amoeboid-like
shape (epithelial-mesenchymal transition). The microenviron-
ment of the tumor plays a significant role in cancer progres-
sion with matrix metalloproteinases acting as regulators, allowing
obstacles to be overcome (Rowe and Weiss, 2009; Kessenbrock
et al., 2010).
Matrix metalloproteinases (MMPs) are one mechanism by
which cancer cells have the ability to invade. These proteolytic
enzymes are a family of 23 enzymes in humans which have the
capacity to degrade virtually all components of the surrounding
tissue (Kleiner and Stetler-Stevenson, 1999). This in turn facili-
tates cancer growth and spread by virtue of the available space left
in the absence of the degraded ECM as well as by other proteins
that are released by the degraded tissue encouraging the cancer
growth (Werb, 1997; López-Otín and Overall, 2002). Haptotaxis is
a process of directed cell migration whereby cells move in response
to gradients of adhesion sites naturally present in the ECM.
MMPs are zinc-dependent endopeptidases whose main func-
tion is in the regular turnover of the ECM (Nagase and Woessner,
1999). This process is exploited in cancer growth and invasion
where various MMPs are over expressed. The expression of MMPs
faces control at the level of transcription but can also face inhibi-
tion when moving from the proMMP state to an active MMP as
well as inhibition when it exists in its active state.
The family of MMPs can exhibit both pro- and anti-invasive
characteristics (Nöel et al., 2012) but in this paper we focus on the
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pro-invasive MMPs of MMP-2, MMP-9, and MT1-MMP. MMP-
2 and MMP-9 are secreted in their inactive zymogen forms of
proMMP-2 and proMMP-9 whereas the fully active MT1-MMP is
expressed on the cell surface after being activated internally. The
activation process by which the various MMPs develop into their
fully active form differs between them. This interplay between the
enzymes is emphasized by the coexpression of proMMP-2, MT1-
MMP, MMP-2, and TIMP2 in a variety of tissues (Kinoh et al.,
1996). While MT1-MMP was initially thought to have activity
limited to activating MMP-2, it has since been found to also have
a direct role in tissue degradation (d’Ortho et al., 1997).
The main constituent of the stroma is the structural, cross-
linked type I collagen. MT1-MMP exhibits strong type I col-
lagenolytic capabilities and weak gelatinolytic capabilities. Con-
versely, MMP-2 exhibits weak type I collagenolytic capabilities and
strong gelatinolytic capabilities (Tam et al., 2004) where it is unable
to degrade cross-linked collagen type I and type IV but is able to
degrade the uncross-linked variants (Zhang et al., 2013). MMP-2
can, however, critically degrade type IV collagen, the main compo-
nent of the basement membrane and an extracellular barrier. As
MT1-MMP is bound to cancer cells, its region of proteolytic activ-
ity is more restricted than that of the freely diffusive proteolytic
enzyme MMP-2. This means that tissue degradation in advance
of the cancer cells is the result of the soluble MMPs. While MT1-
MMP activity is restricted in range, it has an advantage in its
capability of overcoming environments of higher collagen density
such as exists in some peritumoral stroma. Sabeh et al. (2009)
have shown that when cancer cells are faced with structural bar-
riers created in reconstituted gels by covalently cross-linked fibrils
of type I collagen, or that exist in the stromal environment of the
mammary gland, invasion is dependent on MT1-MMP-mediated
proteolysis.
Other mathematical models that have examined the activation
of MMP-2 by MT1-MMP include Karagiannis and Popel (2004),
Donzé et al. (2011), and Hoshino et al. (2012). Karagiannis and
Popel (2004) developed a set of non-spatial ordinary differential
equations of this activation system and examined the interplay
between the activation system of MMP-2 and ectodomain shed-
ding of MT1-MMP. They found that in the absence of TIMP2,
ectodomain shedding of MT1-MMP dominated dynamics but that
introducing TIMP2 would encourage MMP-2 activation and pro-
tect MT1-MMP from shedding. They later developed their model
to examine proteolysis during the migration of a tip endothelial
cell as is relevant in angiogenesis (Karagiannis and Popel, 2006).
Donzé et al. (2011) performed global robustness and sensitivity of
the model and explored the possibility of oscillatory dynamics in
the system. Hoshino et al. (2012) developed their extensive model
of all possible interactions of enzymes using A-Cell (Ichikawa,
2001). They provide experimental validation alongside their com-
putational model used to investigate the significance of turnover
of MT1-MMP for proteolysis at invadopodia. In this paper, we
apply a reduced form of the activation system of MMP-2 to our
model of cancer cell invasion where tissue degradation is mediated
by either MT1-MMP or MMP-2.
The architecture of the ECM plays a pivotal role when consider-
ing cancer cell invasion. Li et al. (2008) and Sabeh et al. (2009) have
made attempts to create in vitro environments that better represent
those found in vivo by embedding multicellular spheroids of HT-
1080 fibrosarcoma cells within gels of cross-linked native type
I collagen. Both studies found that MT1-MMP silencing blocks
virtually all collagenolytic and invasive activity. In this paper, we
provide an approach that considers what effect the architecture of
the ECM, such as pore size of tissue and proportion of ECM made
up of cross-linked collagen, may have when applied to a model
of cancer invasion. We are able to consider a heterogeneous ECM
and incorporate haptotaxis as occurring only in response to ECM
gradients created by the release of enzymes such as MMPs.
In this paper therefore, we develop a mathematical model of
cancer invasion which consider the role of matrix metallopro-
teinases (MMPs). Specifically our model will focus on two distinct
types of MMP, i.e., soluble, diffusible MMPs (e.g., MMP-2), and
membrane-bound MMPs (e.g., MT1-MMP), and the roles each of
these plays in cancer invasion. Our model will also consider the
influence of the structure of the matrix on cancer cell invasion and
to achieve this (using a continuum PDE model) we will introduce
the concept of a “matrix suitability modifier.”
MATERIALS AND METHODS
In this section, we present our mathematical model which
describes the interplay between MMPs in cancer invasion, specif-
ically MT1-MMP activation of MMP-2, the balance between
TIMP2 inhibition of both MT1-MMP and MMP-2, and the dual
role of TIMP2 as inhibitor of species and activator of MMP-2.
The full process of MMP-2 activation is shown in Figure 1. The
species/complexes in a blue box are produced while those in the
black box are simply formed. Whether a species/complex is free
to move, without considering lateral diffusion on a cell and the
relative movement of a cell, is also indicated.
Our invasion model is based on a simplified form of MMP-2
activation as outlined in Figure 2, and involves considering stages
2, 3, and 4 of Figure 1 as a single process. This retains the key
details of whether a complex is stationary or not in relation to cell
movement and is a significant factor considering the relative speed
of binding of the freely diffusive TIMP2 to a complex bound to
the cell. However, we feel that this simplification of the process is
appropriate in capturing the dynamics of the two functional forms
by which invasion is facilitated. A basic model is presented in the
Supplementary Material to clarify the difference between these
two functional forms of invasion mediated by the highly localized
tissue degradation by MT1-MMP and the more extensive tissue
degradation by the diffusible MMP-2.
In our model we denote by c(x, t ) the cancer cell density, v(x, t )
the ECM density,ms(x, t ) the MMP-2 concentration, and by mt(x,
t ) the MT1-MMP concentration. In addition, we letT (x, t ) denote
the TIMP2 concentration, f(x, t ) the concentration of the complex
of MT1-MMP:TIMP2 (with an assumed proMMP-2 attached)
and s(x, t ) the “matrix suitability modifier.” The matrix suitability
modifier acts as an environmental factor by reducing the level of
a cell population that can physically move through the matrix –
as an extension of the volume-filling principles – by taking into
account the pore size of the collagen substrate along with reducing
the amount of matrix that is considered available to be degraded.
In this model, we consider a matrix environment with a neutral
effect on these processes to have a matrix suitability modifier value
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FIGURE 1 | Schematic diagram of MMP-2 activation.
FIGURE 2 | Simplified schematic diagram of MMP-2 activation.
of 1, which results in the standard dynamics expected from such
a model. A matrix environment containing difficult regions of
ECM for cancer cells to invade will be represented by a matrix
suitability modifier with a value 0≤ s< 1, with values toward zero
describing an environment that is more difficult for cancer cells
to navigate through, as well as a reduction in ECM that is avail-
able to be degraded. We also impose the condition that s+ v ≥ 1,
otherwise instead of limiting movement and tissue degradation,
movement would be encouraged in the opposite direction and
the ECM degradation term would cause the density of ECM to
increase.
As both MT1-MMP and the intermediate complex are bound
to cancer cells, they experience movement in the same direction
as the cancer cells and with a magnitude determined by the
concentration of enzymes at that location. We consider both
MMP-2 and MT1-MMP to undergo natural decay. We include
collagen-induced MT1-MMP expression in our model through a
function αmtc(1+ v) (Zigrino et al., 2001). This may take into
account observations showing that collagen-dense mouse mam-
mary tissues result in cancer cells with a more invasive phenotype
Provenzano et al. (2008). We also include volume-filling of the
form (1− c − v) to represent the competition for space between
the cancer cells and ECM. This is applied both to the haptotactic
response of cancer cells to ECM gradients and to the growth rates
for both the cancer cell and ECM populations. Finally, we have an
ECM remodeling rate of µv(1− c − v) (cf. Gerisch and Chaplain
(2008)). The full model is therefore given as:
∂c
∂t
=∇ (Dc∇c − χc (s − 1+ v) (1− c − v)∇v)
+ µc c (1− c − v) , (1)
∂v
∂t
= − δ (s − 1+ v) (ms +mt )+ µv (1− c − v) , (2)
∂ms
∂t
=∇ (Dms∇ms)− φ31Tms + φ32mt f − βmsms , (3)
∂mt
∂t
=mt∇ (Dc∇c − χc (s − 1+ v) (1− c − v)∇v)− φ41Tmt
+ φ42 − βmtmt + αmt c (1+ v) , (4)
∂T
∂t
=∇ (DT∇T )− φ51Tms − φ52Tmt + φ53f + αT c , (5)
∂f
∂t
= f ∇ (Dc∇c − χc (s − 1+ v) (1− c − v)∇v)+ φ61Tmt
− φ62f mt − φ63f , (6)
∂s
∂t
= δsmt (1− s) . (7)
In all computational simulations, we apply zero-flux bound-
ary conditions to equations (1), (3–6). The initial conditions
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imposed depend on the precise invasion scenario we are con-
sidering. In our the first invasion scenario (cf. Figure 3) we
have a cluster of cancer cells in the center of a homoge-
neous ECM with a small amount of activated enzymes already
released, i.e., c (0) = e
(−(x2+y2)
0.02
)
, v(0)=1− c(0)v(0) = 1− c(0),
ms(0) =ms(0) =T (0) = f(0) = c(0)ms(0) = mt (0) = T (0) =
f (0) = c(0). The initial condition for the matrix suitabil-
ity modifier s is best seen in Figure 3C. The initial condi-
tions used for c, v, s in the second invasion scenario are best
seen from the plots in Figures 7A–C, and also in this case
ms(0)=mt(0)=T (0)= f(0)= c(0).
PARAMETER ESTIMATION
We non-dimensionalize the model using the reference variables
τ = 104 s and L= 0.1 cm. While the reference enzyme concentra-
tion can be difficult to obtain, we take it be 1 nM with concentra-
tions throughout the considered timeframe to be within the range
0–25 nM. Tutton et al. (2003) find pre-operative MMP-2 levels
in plasma of colorectal cancer patients of 568.9 ng/ml= 7.89 nM
while Butler et al. (1998) and English et al. (2001) performed
experiments with enzyme concentrations of order 100 nM. The
parametersβms,βmt,αmt, andαT were therefore chosen so that the
concentrations of active MT1-MMP and MMP-2 are in the range
0–25 nM. The baseline parameter set presented in Table 1 is used
for all computational simulations of the model unless otherwise
specified.
RESULTS
In this section we present the computational simulation results of
our invasion model equations (1–7) in a 2-dimensional domain
(all parameter values are from the baseline set). The first scenario
we consider is one in which the tissue is considered to have neutral
effects on invasion in the top half of the domain by having a matrix
suitability modifier s= 1, with the lower half of the domain having
moderate characteristics limiting invasion by having the matrix
suitability modifier of s = 12 , as shown in Figure 3C. The value of
s = 12 may represent a region that contains a tissue where (i) half
the constituent parts of the ECM are cross-linked collagen, (ii) half
the considered ECM has a pore size below a thresholdα that blocks
invasion, (iii) more than half the considered ECM has a pore size
in the range α–β that slows invasion, or (iv) some combination
of the factors presented in (i–iii) that has the equivalent effect. As
can be seen from the plots in Figure 3 we observe an asymmetric
invasion by the cancer cells, with a reduced invasion in the lower
half of the domain (cf. Figure 3D) and also a reduced degradation
of ECM in the lower half of the domain (cf. Figure 3E).
Figures 4 and 5 show the corresponding evolution of the vari-
ous enzyme concentrations using the baseline parameter set. The
plots in Figures 4F and 5F show that any free TIMP2 that is pro-
duced or released from a complex is quickly bound to either free
MT1-MMP or MMP-2. The plots in Figures 4D and 5D show that
while MMP-2 can freely diffuse throughout the environment, its
profile is affected by the source term coming from the asymmet-
ric cancer cell invasion dynamics. The plots in Figures 4E and 5E
show how the degradative effect of MT1-MMP is limited by its
dependence on transport by the cancer cells. This is demonstrated
by a reduced invasive profile in the bottom half of each plot.
In Figure 6 we examine an invasive scenario where the effects of
the suitability of the matrix play little or no role. This is achieved by
increasing the parameter δs to a value of 10 (all other parameters
FIGURE 3 | Plots showing the simulation results obtained in a
two-dimensional domain where asymmetric invasion of the ECM is
achieved by the cancer cells. We use the matrix suitability modifier s to
represent a medium with neutral abilities in the upper half of the region
(s= 1; red) and with a reduced, moderate, suitability for invasion in the
lower half (s=0.5; green). Plots (A–C) show the initial values of the cancer
cell and ECM densities as well as the initial layout of the matrix suitability
modifier with (D–F) showing their resultant profiles at t =40
(corresponding to ∼4.6 days). Simulations are performed using the
baseline parameter set.
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Table 1 | Baseline parameter set for the model.
Non-dimensional
form
Original Unit Reference
Dc 3.5×10-4 Anderson et al. (2000)
χ 5×10-3 Anderson et al. (2000)
µc 0.3 Anderson et al. (2000)
δ 1 Anderson et al. (2000)
µv 0.2 Anderson et al. (2000)
Dms 1.29×102 1.29×108 cm2s−1 Collier et al. (2011)
φ31 5 5×105 M−1s−1 Estimated
φ32 0.195 1.95×104 M−1s−1 Estimated
βms 0.1 D 1×10-5 s−1 Estimated
αmt 5 5×10-4 s−1 Estimated
φ41 27.4 2.74×106 M−1s−1 Toth et al. (2000)
φ42 2 2×10-4 s−1 Toth et al. (2000)
βmt 0.1 1×10-5 s−1 Estimated
DT 1.29×102 1.29×108 cm2s−1 Collier et al. (2011)
αT 4 4×10-4 s−1 Estimated
φ51 5 5×105 M−1s−1 Estimated
φ52 27.4 2.74×106 M−1s−1 Toth et al. (2000)
φ53 2 2×10-4 s−1 Toth et al. (2000)
φ61 27.4 2.74×106 M−1s−1 Toth et al. (2000)
φ62 0.195 1.95×104 M−1s−1 Estimated
φ63 2 2×10-4 s−1 Toth et al. (2000)
δs 0.025 Estimated
kept at baseline values and using the same initial conditions as in
Figures 3 and 4). This scenario represents a region of tissue that is
difficult to invade and degrade by MMP-2 alone in the lower half
of the domain, but one that is rapidly remodeled when in range
of MT1-MMP to a condition that is considered to have a neutral
effect on invasion. Under these conditions, it can be seen from
the plot in Figure 6D that the cancer cells invade in a symmetric
manner (unlike the scenario in Figure 3D). However, we can also
see from the plot in Figure 6E that there is a reduced degradation
of ECM due to MMP-2 in the lower half of the domain compared
with the upper half. This shows the significance of the rate that
MT1-MMP is able to remodel the ECM in the spatial layout of
the tumor. The corresponding plots of the concentrations MMP-
2, MT1-MMP, the intermediary complex f, and TIMP2 at t = 20
and t = 40 are given in Figures S2 and S3 of the Supplementary
Material.
In Figure 7, we present the computational simulation results
of cancer cell invasion in a more heterogeneous environment such
as would be expected in certain in vitro experiments (and also
in vivo). For this scenario, we used the baseline parameter set,
except for the parameter δs which is reduced by a factor of ten to
a value of 0.0025. The plots in Figures 7D–F show that the cancer
cells take a longer time to invade the less suitable regions of ECM
resulting in a heterogeneous invasion pattern. In Figure 7F, we
can see that there are regions of higher cancer cell density (small
red zones) in advance of regions of lower cancer cell density (small
green zones) but without having broken off from the main mass
entirely. The corresponding plots of the concentrations of MMP-2
and MT1-MMP at t = 10, 50, 100 are given in Figure S4 of the
Supplementary Material. The effect of varying the parameter δs
can be seen by comparing the results in Figure 7 with Figure S5
FIGURE 4 | Plots showing the simulation results obtained in a
two-dimensional domain where asymmetric invasion of the ECM is
achieved by the cancer cells. The concentrations of MMP-2, MT1-MMP,
the intermediary complex f, and TIMP2 at t =20 (corresponding to
∼2.3 days) are shown in plots (A–C,F) respectively. Plots (D,E) show the
MMP-2 and MT1-MMP concentrations at t =20 with appropriate
thresholds near the invasive front of the cancer cell invasion. The white
contour line shows the cancer cell density at level 0.01 chosen to
represent the maximum extent of invasion. Simulations are performed
using the baseline parameter set.
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FIGURE 5 | Plots showing the simulation results obtained in a
two-dimensional domain where asymmetric invasion of the ECM is
achieved by the cancer cells. The concentrations of MMP-2, MT1-MMP,
the intermediary complex f, and TIMP2 at t =40 (corresponding to
∼4.6 days) are shown in plots (A–C,F) respectively. Plots (D,E) show the
MMP-2 and MT1-MMP concentrations at t =40 with appropriate
thresholds near the invasive front of the cancer cell invasion. The white
contour line shows the cancer cell density at level 0.01 chosen to
represent the maximum extent of invasion. Simulations are performed
using the baseline parameter set.
FIGURE 6 | Plots showing the simulation results obtained in a
two-dimensional domain where the suitability modifier s represents a
medium with neutral abilities in the upper half of the region (s=1; red)
and a reduced, moderate, suitability for invasion in the lower half
(s=0.5; green). We consider a scenario where the suitability modifier is
rapidly brought back to a neutral state by performing simulations using the
baseline parameter set with the exception of δs =10. Plots (A–C) show the
initial values of the cancer cell and ECM densities as well as the initial layout
of the matrix suitability modifier with plots (D–F) showing their resultant
profiles at t =40 (corresponding to ∼4.6 days). As can be seen, in this case
there is an almost symmetric invasion pattern. This shows the influence of the
parameter δs on invasion.
in the Supplementary Material, where we have used the default
parameter set but we do not observe any regions of high cancer
cell density in advance of regions of lower cancer cell density.
DISCUSSION
In this paper we have presented a mathematical model for can-
cer invasion of tissue, focusing on the roles of soluble and
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FIGURE 7 | Plots showing the simulation results obtained in a
two-dimensional domain with a spatially complex matrix suitability
modifier s to more accurately depict the observations of certain in vivo
experiments. Plots (A–C) show the initial values of the cancer cell and ECM
densities as well as the initial structure of the matrix suitability modifier. Plots
(D–F) show the resultant profiles of cancer cell density at t =10, 50, and 100
(corresponding to ∼1.15, 5.75, and 11.5 days, respectively). The white contour
line shows the cancer cell density at level 0.01 chosen to represent the
maximum extent of invasion. Plots (G–I) show the resultant profiles of ECM
density at t =10, 50, and 100. The simulations were performed using the
baseline parameter set with the exception of the parameter δs =0.0025. The
plots show a highly heterogeneous invasion pattern at the invasive front, once
again highlighting the role of the matrix suitability modifier s and the
parameter δs.
bound MMPs. Additionally we introduced the concept of “matrix
suitability,”governed by the variable s in our model. By considering
the suitability of the matrix as a factor affecting ECM degradation
and the movement of enzymes and cancer cells, we were able to
generate heterogeneity in the ECM caused solely by matrix degra-
dation. This meant we were able to focus on the effects of these
gradients explicitly caused by matrix degradation rather than ECM
density gradients due to intrinsic tissue heterogeneity. The com-
putational simulation results showed that the matrix suitability
modifier and its regulation played an important role in determin-
ing the precise pattern of invasion. As has been observed in the
experimental data of Sabeh et al. (2009) and Li et al. (2008), we
have shown that the architecture of the tissue can negatively impact
invasion under circumstances of pore size being below an optimal
level or in environments of cross-linked collagen type I and IV,
with both of these conditions requiring tissue remodeling specifi-
cally by MT1-MMP. In addition to this, invasion is reduced where
TIMP2 is overly produced. To investigate the matrix suitability
modifier from a biological perspective, experiments would need to
be carried out to obtain the initial layout of the suitability modifier
as well as the parameter δs. The first step in doing this would be
to find out the effects of different tissue pore size on cancer cell
migration to establish what range of pore sizes would be consid-
ered a neutral modifier, what range of pore sizes allow migration
at reduced levels, and what range of pore sizes completely block
migration. This could be done by using the approaches of Nys-
tröm et al. (2005) and Martins et al. (2009) where they performed
in vitro experiments using a collagen:matrigel assay to investigate
the invasiveness of cancer cells to establish a quantitative “inva-
sive index” in organotypic cultures. Once there is quantitative
data for these effects, obtaining data on the structure of the tis-
sue through effective imaging techniques such as those described
in Wolf et al. (2009) would allow one to generate realistic ini-
tial conditions of the matrix suitability modifier. An estimate of
the parameter δs could then be obtained by validating the model
against experiments similar to those found in Sabeh et al. (2009) or
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Li et al. (2008), who performed in vitro experiments using a cross-
linked native type I collagen assay to investigate the importance of
MT1-MMP in cancer invasion.
Future work in developing the model will involve a parameter
sensitivity analysis for the system. However, one observation that
we have already noticed is that by increasing the production of
TIMP2 to 10 times its original value (i.e., αT= 40) greatly reduces
matrix degradation over the time interval considered and the can-
cer cell population increases by only 56% from its initial value
(see Figure S7 in the Supplementary Material). This is due to an
abundance of TIMP2 molecules binding to MT1-MMP molecules
before free MT1-MMP are able to take part in activating MMP-2,
as described in stage 2 of Figure 2. These observations are in line
with the observed biological results of Strongin et al. (1995), Sabeh
et al. (2009). We also note that for low levels of TIMP2 production,
activation of MMP-2 is reduced while the concentration of active
MT1-MMP is increased and the total level of ECM degradation is
reduced.
We will also consider a more detailed activation system for
MMP-2. While we reduced the full activation system of MMP-
2 (shown in Figure 1) to the simpler system used in the model
(shown in Figure 2), it is not clear if the activation system
of Figure 1 captures the full range of dynamics involved in
this process. Another component of the activation system which
could be considered is an intermediate form of MMP-2 occur-
ring between the proMMP-2 and fully active MMP-2. In our
model, there is no intermediate form of MMP-2, since we assume
proMMP-2 is in abundance and always present in the MT1-
MMP:TIMP2 complex. To consider any complementary effects
of further activation systems of MMP-2 on cancer cell invasion,
they must first be established. Lafleur et al. (2003) have proposed
that proMMP-2 binds to a different cell receptor than is mod-
eled in our current model of the MT1-MMP:TIMP2 complex.
The proMMP-2 is the processed into an intermediate form of
MMP-2 before binding to the MT1-MMP:TIMP2 complex and
auto-catalyzing into active MMP-2. Investigations into further
activation systems by focusing on each stage of Figure 1 may
be helped by the work of Nishida et al. (2008) who showed
that an artificial receptor for proMMP-2 was able to take the
place of the MT1-MMP:TIMP2 complex in binding proMMP-
2 to the cell surface without inhibiting active MT1-MMP or
MMP-2. In order to gain the full benefit of such modeling
efforts (at the cell and receptor scale), we will also require to
adapt the current model to take into account novel multi-scale
modeling approaches, some of which have already been formu-
lated specifically to investigate cancer invasion [cf. Trucu et al.
(2013)].
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